Tert-butylhydroquinone post-treatment attenuates neonatal hypoxic-ischemic brain damage in rats

Hypoxic-ischemic (HI) encephalopathy is a leading cause of dire mortality and morbidity in neonates. Unfortunately, no effective therapies have been developed as of yet. Oxidative stress plays a critical role in pathogenesis and progression of neonatal HI. Previously, as a Nrf2 activator, tert-butyl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurochemistry international 2018-06, Vol.116, p.1-12
Hauptverfasser: Zhang, Juan, Tucker, Lorelei Donovan, DongYan, Lu, Yujiao, Yang, Luodan, Wu, Chongyun, Li, Yong, Zhang, Quanguang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue
container_start_page 1
container_title Neurochemistry international
container_volume 116
creator Zhang, Juan
Tucker, Lorelei Donovan
DongYan
Lu, Yujiao
Yang, Luodan
Wu, Chongyun
Li, Yong
Zhang, Quanguang
description Hypoxic-ischemic (HI) encephalopathy is a leading cause of dire mortality and morbidity in neonates. Unfortunately, no effective therapies have been developed as of yet. Oxidative stress plays a critical role in pathogenesis and progression of neonatal HI. Previously, as a Nrf2 activator, tert-butylhydroquinone (TBHQ) has been demonstrated to exert neuroprotection on brain trauma and ischemic stroke models, as well as oxidative stress-induced cytotoxicity in neurons. It is, however, still unknown whether TBHQ administration can protect against oxidative stress in neonatal HI brain injury. This study was undertaken to determine the neuroprotective effects and mechanisms of TBHQ post-treatment on neonatal HI brain damage. Using a neonatal HI rat model, we demonstrated that TBHQ markedly abated oxidative stress compared to the HI group, as evidenced by decreased oxidative stress indexes, enhanced Nrf2 nuclear accumulation and DNA binding activity, and up-regulated expression of Nrf2 downstream antioxidative genes. Administration of TBHQ likewise significantly suppressed reactive gliosis and release of inflammatory cytokines, and inhibited apoptosis and neuronal degeneration in the neonatal rat cerebral cortex. In addition, infarct size and neuronal damage were attenuated distinctly. These beneficial effects were accompanied by improved neurological reflex and motor coordination as well as amelioration of spatial learning and memory deficits. Overall, our results provide the first documentation of the beneficial effects of TBHQ in neonatal HI model, in part conferred by activation of Nrf2 mediated antioxidative signaling pathways. •Tert-butylhydroquinone (TBHQ) reduces infarct size in hypoxic-ischemic (HI) rats.•TBHQ ameliorates neurobehavioral deficits after HI brain damage.•TBHQ promotes Nrf2 nuclear activation and attenuates oxidative damage after HI.•TBHQ suppresses neuroinflammation in the cerebral cortex after HI brain damage.•TBHQ inhibits HI-induced neuronal apoptosis and reduces neuronal cell death.
doi_str_mv 10.1016/j.neuint.2018.03.004
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5895521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0197018617304655</els_id><sourcerecordid>2013518583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-394ca800201c8c4d4a8c37abf12043c60c9c5b5c7cd13ffcac0035674521c3c73</originalsourceid><addsrcrecordid>eNp9UcFu1DAQtRCIbgt_gFCOXJKOYztxLkioAlqpEpdytpzJpOtV4iy2U7F_X6-2FLj0NCPNvDfvzWPsA4eKA28ud5Wn1flU1cB1BaICkK_Yhuu2LrtWyddsA7xryzxtzth5jDsAaDtQb9lZ3SkBrdIbZu4opLJf02HaHoaw_MqUi6div8RUpkA2zeRTYVMiv9pEsfC0eJvsVGwP--W3w9JF3NLssOiDdb4Y7GzvqchdsCm-Y29GO0V6_1Qv2M9vX--ursvbH99vrr7cligbkUrRSbQaIHtBjXKQVqNobT_yGqTABrBD1StsceBiHNEigFBNK1XNUWArLtjnE-9-7WcaMIsOdjL74GYbDmaxzvw_8W5r7pcHo3SnMkkm-PREcHwCxWTmbIymyWbDazRZmVBcKy3yqjytYlhiDDQ-n-FgjtmYnTllc0RpA8LkbDLs478Sn0F_wvjrgfKjHhwFE9GRRxpcIExmWNzLFx4BDjWlqg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2013518583</pqid></control><display><type>article</type><title>Tert-butylhydroquinone post-treatment attenuates neonatal hypoxic-ischemic brain damage in rats</title><source>Access via ScienceDirect (Elsevier)</source><creator>Zhang, Juan ; Tucker, Lorelei Donovan ; DongYan ; Lu, Yujiao ; Yang, Luodan ; Wu, Chongyun ; Li, Yong ; Zhang, Quanguang</creator><creatorcontrib>Zhang, Juan ; Tucker, Lorelei Donovan ; DongYan ; Lu, Yujiao ; Yang, Luodan ; Wu, Chongyun ; Li, Yong ; Zhang, Quanguang</creatorcontrib><description>Hypoxic-ischemic (HI) encephalopathy is a leading cause of dire mortality and morbidity in neonates. Unfortunately, no effective therapies have been developed as of yet. Oxidative stress plays a critical role in pathogenesis and progression of neonatal HI. Previously, as a Nrf2 activator, tert-butylhydroquinone (TBHQ) has been demonstrated to exert neuroprotection on brain trauma and ischemic stroke models, as well as oxidative stress-induced cytotoxicity in neurons. It is, however, still unknown whether TBHQ administration can protect against oxidative stress in neonatal HI brain injury. This study was undertaken to determine the neuroprotective effects and mechanisms of TBHQ post-treatment on neonatal HI brain damage. Using a neonatal HI rat model, we demonstrated that TBHQ markedly abated oxidative stress compared to the HI group, as evidenced by decreased oxidative stress indexes, enhanced Nrf2 nuclear accumulation and DNA binding activity, and up-regulated expression of Nrf2 downstream antioxidative genes. Administration of TBHQ likewise significantly suppressed reactive gliosis and release of inflammatory cytokines, and inhibited apoptosis and neuronal degeneration in the neonatal rat cerebral cortex. In addition, infarct size and neuronal damage were attenuated distinctly. These beneficial effects were accompanied by improved neurological reflex and motor coordination as well as amelioration of spatial learning and memory deficits. Overall, our results provide the first documentation of the beneficial effects of TBHQ in neonatal HI model, in part conferred by activation of Nrf2 mediated antioxidative signaling pathways. •Tert-butylhydroquinone (TBHQ) reduces infarct size in hypoxic-ischemic (HI) rats.•TBHQ ameliorates neurobehavioral deficits after HI brain damage.•TBHQ promotes Nrf2 nuclear activation and attenuates oxidative damage after HI.•TBHQ suppresses neuroinflammation in the cerebral cortex after HI brain damage.•TBHQ inhibits HI-induced neuronal apoptosis and reduces neuronal cell death.</description><identifier>ISSN: 0197-0186</identifier><identifier>EISSN: 1872-9754</identifier><identifier>DOI: 10.1016/j.neuint.2018.03.004</identifier><identifier>PMID: 29530758</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Neonatal hypoxia-ischemia ; Neuroprotection ; Nrf2 ; Oxidative stress ; Tert-butylhydroquinone</subject><ispartof>Neurochemistry international, 2018-06, Vol.116, p.1-12</ispartof><rights>2018 Elsevier Ltd</rights><rights>Copyright © 2018 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-394ca800201c8c4d4a8c37abf12043c60c9c5b5c7cd13ffcac0035674521c3c73</citedby><cites>FETCH-LOGICAL-c463t-394ca800201c8c4d4a8c37abf12043c60c9c5b5c7cd13ffcac0035674521c3c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neuint.2018.03.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29530758$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Juan</creatorcontrib><creatorcontrib>Tucker, Lorelei Donovan</creatorcontrib><creatorcontrib>DongYan</creatorcontrib><creatorcontrib>Lu, Yujiao</creatorcontrib><creatorcontrib>Yang, Luodan</creatorcontrib><creatorcontrib>Wu, Chongyun</creatorcontrib><creatorcontrib>Li, Yong</creatorcontrib><creatorcontrib>Zhang, Quanguang</creatorcontrib><title>Tert-butylhydroquinone post-treatment attenuates neonatal hypoxic-ischemic brain damage in rats</title><title>Neurochemistry international</title><addtitle>Neurochem Int</addtitle><description>Hypoxic-ischemic (HI) encephalopathy is a leading cause of dire mortality and morbidity in neonates. Unfortunately, no effective therapies have been developed as of yet. Oxidative stress plays a critical role in pathogenesis and progression of neonatal HI. Previously, as a Nrf2 activator, tert-butylhydroquinone (TBHQ) has been demonstrated to exert neuroprotection on brain trauma and ischemic stroke models, as well as oxidative stress-induced cytotoxicity in neurons. It is, however, still unknown whether TBHQ administration can protect against oxidative stress in neonatal HI brain injury. This study was undertaken to determine the neuroprotective effects and mechanisms of TBHQ post-treatment on neonatal HI brain damage. Using a neonatal HI rat model, we demonstrated that TBHQ markedly abated oxidative stress compared to the HI group, as evidenced by decreased oxidative stress indexes, enhanced Nrf2 nuclear accumulation and DNA binding activity, and up-regulated expression of Nrf2 downstream antioxidative genes. Administration of TBHQ likewise significantly suppressed reactive gliosis and release of inflammatory cytokines, and inhibited apoptosis and neuronal degeneration in the neonatal rat cerebral cortex. In addition, infarct size and neuronal damage were attenuated distinctly. These beneficial effects were accompanied by improved neurological reflex and motor coordination as well as amelioration of spatial learning and memory deficits. Overall, our results provide the first documentation of the beneficial effects of TBHQ in neonatal HI model, in part conferred by activation of Nrf2 mediated antioxidative signaling pathways. •Tert-butylhydroquinone (TBHQ) reduces infarct size in hypoxic-ischemic (HI) rats.•TBHQ ameliorates neurobehavioral deficits after HI brain damage.•TBHQ promotes Nrf2 nuclear activation and attenuates oxidative damage after HI.•TBHQ suppresses neuroinflammation in the cerebral cortex after HI brain damage.•TBHQ inhibits HI-induced neuronal apoptosis and reduces neuronal cell death.</description><subject>Neonatal hypoxia-ischemia</subject><subject>Neuroprotection</subject><subject>Nrf2</subject><subject>Oxidative stress</subject><subject>Tert-butylhydroquinone</subject><issn>0197-0186</issn><issn>1872-9754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9UcFu1DAQtRCIbgt_gFCOXJKOYztxLkioAlqpEpdytpzJpOtV4iy2U7F_X6-2FLj0NCPNvDfvzWPsA4eKA28ud5Wn1flU1cB1BaICkK_Yhuu2LrtWyddsA7xryzxtzth5jDsAaDtQb9lZ3SkBrdIbZu4opLJf02HaHoaw_MqUi6div8RUpkA2zeRTYVMiv9pEsfC0eJvsVGwP--W3w9JF3NLssOiDdb4Y7GzvqchdsCm-Y29GO0V6_1Qv2M9vX--ursvbH99vrr7cligbkUrRSbQaIHtBjXKQVqNobT_yGqTABrBD1StsceBiHNEigFBNK1XNUWArLtjnE-9-7WcaMIsOdjL74GYbDmaxzvw_8W5r7pcHo3SnMkkm-PREcHwCxWTmbIymyWbDazRZmVBcKy3yqjytYlhiDDQ-n-FgjtmYnTllc0RpA8LkbDLs478Sn0F_wvjrgfKjHhwFE9GRRxpcIExmWNzLFx4BDjWlqg</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Zhang, Juan</creator><creator>Tucker, Lorelei Donovan</creator><creator>DongYan</creator><creator>Lu, Yujiao</creator><creator>Yang, Luodan</creator><creator>Wu, Chongyun</creator><creator>Li, Yong</creator><creator>Zhang, Quanguang</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180601</creationdate><title>Tert-butylhydroquinone post-treatment attenuates neonatal hypoxic-ischemic brain damage in rats</title><author>Zhang, Juan ; Tucker, Lorelei Donovan ; DongYan ; Lu, Yujiao ; Yang, Luodan ; Wu, Chongyun ; Li, Yong ; Zhang, Quanguang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-394ca800201c8c4d4a8c37abf12043c60c9c5b5c7cd13ffcac0035674521c3c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Neonatal hypoxia-ischemia</topic><topic>Neuroprotection</topic><topic>Nrf2</topic><topic>Oxidative stress</topic><topic>Tert-butylhydroquinone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Juan</creatorcontrib><creatorcontrib>Tucker, Lorelei Donovan</creatorcontrib><creatorcontrib>DongYan</creatorcontrib><creatorcontrib>Lu, Yujiao</creatorcontrib><creatorcontrib>Yang, Luodan</creatorcontrib><creatorcontrib>Wu, Chongyun</creatorcontrib><creatorcontrib>Li, Yong</creatorcontrib><creatorcontrib>Zhang, Quanguang</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurochemistry international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Juan</au><au>Tucker, Lorelei Donovan</au><au>DongYan</au><au>Lu, Yujiao</au><au>Yang, Luodan</au><au>Wu, Chongyun</au><au>Li, Yong</au><au>Zhang, Quanguang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tert-butylhydroquinone post-treatment attenuates neonatal hypoxic-ischemic brain damage in rats</atitle><jtitle>Neurochemistry international</jtitle><addtitle>Neurochem Int</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>116</volume><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>0197-0186</issn><eissn>1872-9754</eissn><abstract>Hypoxic-ischemic (HI) encephalopathy is a leading cause of dire mortality and morbidity in neonates. Unfortunately, no effective therapies have been developed as of yet. Oxidative stress plays a critical role in pathogenesis and progression of neonatal HI. Previously, as a Nrf2 activator, tert-butylhydroquinone (TBHQ) has been demonstrated to exert neuroprotection on brain trauma and ischemic stroke models, as well as oxidative stress-induced cytotoxicity in neurons. It is, however, still unknown whether TBHQ administration can protect against oxidative stress in neonatal HI brain injury. This study was undertaken to determine the neuroprotective effects and mechanisms of TBHQ post-treatment on neonatal HI brain damage. Using a neonatal HI rat model, we demonstrated that TBHQ markedly abated oxidative stress compared to the HI group, as evidenced by decreased oxidative stress indexes, enhanced Nrf2 nuclear accumulation and DNA binding activity, and up-regulated expression of Nrf2 downstream antioxidative genes. Administration of TBHQ likewise significantly suppressed reactive gliosis and release of inflammatory cytokines, and inhibited apoptosis and neuronal degeneration in the neonatal rat cerebral cortex. In addition, infarct size and neuronal damage were attenuated distinctly. These beneficial effects were accompanied by improved neurological reflex and motor coordination as well as amelioration of spatial learning and memory deficits. Overall, our results provide the first documentation of the beneficial effects of TBHQ in neonatal HI model, in part conferred by activation of Nrf2 mediated antioxidative signaling pathways. •Tert-butylhydroquinone (TBHQ) reduces infarct size in hypoxic-ischemic (HI) rats.•TBHQ ameliorates neurobehavioral deficits after HI brain damage.•TBHQ promotes Nrf2 nuclear activation and attenuates oxidative damage after HI.•TBHQ suppresses neuroinflammation in the cerebral cortex after HI brain damage.•TBHQ inhibits HI-induced neuronal apoptosis and reduces neuronal cell death.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29530758</pmid><doi>10.1016/j.neuint.2018.03.004</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0197-0186
ispartof Neurochemistry international, 2018-06, Vol.116, p.1-12
issn 0197-0186
1872-9754
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5895521
source Access via ScienceDirect (Elsevier)
subjects Neonatal hypoxia-ischemia
Neuroprotection
Nrf2
Oxidative stress
Tert-butylhydroquinone
title Tert-butylhydroquinone post-treatment attenuates neonatal hypoxic-ischemic brain damage in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T04%3A59%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tert-butylhydroquinone%20post-treatment%20attenuates%20neonatal%20hypoxic-ischemic%20brain%20damage%20in%20rats&rft.jtitle=Neurochemistry%20international&rft.au=Zhang,%20Juan&rft.date=2018-06-01&rft.volume=116&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=0197-0186&rft.eissn=1872-9754&rft_id=info:doi/10.1016/j.neuint.2018.03.004&rft_dat=%3Cproquest_pubme%3E2013518583%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2013518583&rft_id=info:pmid/29530758&rft_els_id=S0197018617304655&rfr_iscdi=true